{
}
Rising healthcare costs are straining patients, payers, and providers, limiting access to care and pressuring the pharmaceutical industry to maintain lower prices. The global pharmaceuticals and healthcare market is projected to grow from $1,245.88 billion in 2021 to $1,924.24 billion by 2032, driven by technological advances and demographic changes. However, regulatory barriers and increasing costs pose significant challenges to market growth.
Investing in healthcare ETFs offers Canadian investors a way to diversify their portfolios, which are often underweight in this sector. Despite its volatility, the healthcare sector is expected to see growth driven by an aging population, technological advancements, and increased healthcare spending. Funds like the Hamilton Healthcare Yield Maximizer ETF and Harvest Healthcare Leaders Income ETF utilize covered call strategies to enhance yields, appealing to those seeking defensive investments with growth potential.
U.S. health care stocks have rebounded in 2024, up 12.3% year-to-date, following two years of sluggish performance. Key ETFs like the iShares Global Healthcare ETF and Vanguard Health Care ETF are capitalizing on this growth, driven by technological advancements and an aging population. With a focus on biopharma and emerging sectors, these funds offer investors a promising entry into the $4.8 trillion health care industry.
Merck & Co., Inc.
Companies
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
global pharmaceutical and healthcare market projected to reach 1924 billion by 2032
United States Dollar
Hoffmann-La Roche AG
Johnson & Johnson
Novartis AG
Merck & Co., Inc.
AbbVie Inc.
CAN
FRA
GBR
USA
ISR
JPN
DNK
DEU
Merck & Co
Roche
Johnson & Johnson
AbbVie
Novartis
Show more
09:00 07.10.2024
healthcare etfs offer growth potential and defensive investment strategies
Eli Lilly and Company
Intuitive Surgical, Inc.
UnitedHealth Group Incorporated
Novo Nordisk A/S
Amgen Inc.
Thermo Fisher Scientific Inc.
Zoetis Inc.
Pfizer Inc.
Merck & Co., Inc.
Agilent Technologies, Inc.
Stryker Corporation
Johnson & Johnson
CAN
USA
Chris Cullen
Novo Nordisk A/S
Mike Clare
Paul MacDonald
Nick Piquard
Show more
09:00 03.10.2024
health care etfs show promise as sector rebounds in 2024
Eli Lilly and Company
Novo Nordisk A/S
Merck & Co., Inc.
AstraZeneca PLC
USA
AstraZeneca PLC
Novo Nordisk A/S
Merck & Co. Inc.
Eli Lilly
Show more
09:00 27.09.2024
Trending
Subcategory
Stock Market Updates
Industry Trends
Corporate News
Retail and Consumer Goods
Global Financial Events
Finance Mergers & Acquisitions
Startups & Entrepreneurship
AI Innovations
Government Policies
Market Analysis and Predictions
Central Bank Actions
Industry Mergers & Acquisitions
Banking Regulations
Supply Chain Management
Domestic Politics
Funding Rounds & Investments
Global Trade Developments
Cryptocurrency Trends
Emerging Startups
Government Economic Policies
Countries:
Companies:
NVIDIA Corporation
Apple Inc.
Tesla, Inc.
Huawei Technologies CO. Ltd.
The Goldman Sachs Group, Inc.
Citigroup Inc.
Barclays PLC
Wells Fargo & Company
American Express Co
Bank of America Corporation
Tiktok USD
HSBC Holdings plc
Berkshire Hathaway Inc.
International Monetary Fund FUND
HDFC Bank Ltd
Coca-Cola FEMSA, S.A.B. de C.V.
Nintendo Co., Ltd.
Raiffeisen Bank International AG
Pfizer Inc.
VP Bank AG
Currencies:
United States Dollar
Euro
Japanese Yen
Indian Rupee
Chinese Yuan
United Arab Emirates Dirham
Swiss Franc
British Pound Sterling
Offshore Chinese Yuan
Brazilian Real
Saudi Riyal
Australian Dollar
South Korean Won
Hong Kong Dollar
Norwegian Krone
People: